{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:19:25Z","timestamp":1784697565642,"version":"3.55.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Cancer Nurs"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The optimal route for immediate-release morphine administration is controversial. The known physical characteristics of morphine that allow absorption are counter to the unproven belief that sublingual morphine is absorbed more quickly.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The aim of this study was to compare swallowed and sublingual morphine for effects on plasma morphine concentrations (PMCs), pain relief, and taste.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Ten participants with cancer (mean age, 50 \u00b1 12 years) received a 10-mg morphine tablet in a randomized crossover design with repeated premeasure and postmeasure for 60 minutes. Measures included PMC and visual analog scale (100 mm) scores for pain relief and taste.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Interindividual variability in maximum PMC was 25-fold (2.2\u201355 ng\/mL). At 60 minutes, sublingual and swallowed routes were not significantly different for mean area under the curve for PMC (swallowed, 329 \u00b1 314 ng\/mL; sublingual, 314 \u00b1 299 ng\/mL) or for mean pain relief scores (swallowed, 81 \u00b1 32; sublingual, 78 \u00b1 31). Taste scores at 5 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .05), 10 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .04), 15 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .02), and 20 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .04) minutes after swallowed doses were significantly less unpleasant than after sublingual doses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In this crossover design, between-group PMCs were similar for sublingual and swallowed morphine and resulted in a similar level of pain relief. Given the 25-fold across-participant differences in PMC after the same dose, additional research is warranted to identify the sources of this tremendous variability in PMC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Implications for Practice<\/jats:title>\n            <jats:p>Because of unpleasant taste, which could influence adherence and subsequent analgesia, clinicians should encourage patients to swallow their morphine doses and restrict use of sublingual morphine to individuals who are unable to swallow.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ncc.0000000000000784","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T02:07:02Z","timestamp":1577671622000},"page":"E13-E22","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Sublingual Versus Swallowed Morphine"],"prefix":"10.1097","volume":"44","author":[{"given":"Brenda W.","family":"Dyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keesha L.","family":"Powell-Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Robison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethaney","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saunjoo L.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana J.","family":"Wilkie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,12,30]]},"reference":[{"key":"bib1-20250618","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/1158412-S0-000000000-00000","article-title":"Time to pain relief after immediate-release morphine in episodic pain: the TIME study","volume":"30","year":"2010","journal-title":"Clin Drug Investig"},{"issue":"5","key":"bib2-20250618","first-page":"941","article-title":"Pain control with sublingual or buccal morphine","volume":"18","year":"1991","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"bib3-20250618","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/104990918700400207","article-title":"Pain control with sublingual morphine. The advantages for hospice care","volume":"4","year":"1987","journal-title":"Am J Hosp Care"},{"issue":"2","key":"bib4-20250618","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/jpm.2006.0150","article-title":"Rational use of sublingual opioids in palliative medicine","volume":"10","year":"2007","journal-title":"J Palliat Med"},{"issue":"4","key":"bib5-20250618","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0029-6465(22)00117-7","article-title":"Sublingual and oral morphine administration. Review and new findings","volume":"30","year":"1995","journal-title":"Nurs Clin North Am"},{"issue":"5","key":"bib6-20250618","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1081\/DDC-120037477","article-title":"Taste masking technologies in oral pharmaceuticals: recent developments and approaches","volume":"30","year":"2004","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"bib8-20250618","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00520-002-0407-7","article-title":"Xerostomia and hypofunction of the salivary glands in cancer therapy","volume":"11","year":"2003","journal-title":"Support Care Cancer"},{"issue":"10","key":"bib9-20250618","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/cncr.10938","article-title":"Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma","volume":"95","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"bib10-20250618","first-page":"585","article-title":"Sublingual morphine sulfate in chronic pain management","volume":"3","year":"1984","journal-title":"Clin Pharm"},{"issue":"4","key":"bib11-20250618","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0031-6989(82)80107-0","article-title":"Control of chronic pain in very advanced cancer patients with morphine hydrochloride administered by oral, rectal and sublingual route. Clinical report and preliminary results on morphine pharmacokinetics","volume":"14","year":"1982","journal-title":"Pharmacol Res Commun"},{"issue":"2","key":"bib12-20250618","first-page":"66","article-title":"Morphine sulfate administered sublingually to control chronic pain","volume":"14","year":"1987","journal-title":"Oncol Nurs Forum"},{"issue":"7","key":"bib13-20250618","first-page":"939","article-title":"Sublingual morphine. A novel route of narcotic administration","volume":"84","year":"1984","journal-title":"Am J Nurs"},{"issue":"2","key":"bib14-20250618","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0269881104042634","article-title":"Oral transmucosal abuse of transdermal fentanyl","volume":"18","year":"2004","journal-title":"J Psychopharmacol"},{"issue":"2","key":"bib15-20250618","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"bib16-20250618","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/clpt.1990.2","article-title":"Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide","volume":"47","year":"1990","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"bib17-20250618","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/clpt.1988.159","article-title":"Sublingual absorption of selected opioid analgesics","volume":"44","year":"1988","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"bib19-20250618","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/clpt.1981.214","article-title":"Morphine kinetics in cancer patients","volume":"30","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"bib20-20250618","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/082585979100700105","article-title":"Rectal, buccal, and sublingual narcotics for the management of cancer pain [see comments]","volume":"7","year":"1991","journal-title":"J Palliat Care"},{"issue":"5","key":"bib24-20250618","first-page":"E732","article-title":"Mucositis in irradiated cancer patients: effects of an antiseptic mouthrinse","volume":"15","year":"2010","journal-title":"Medicina Oral Patologia Oral Y Cirugia Bucal"},{"issue":"2 suppl","key":"bib25-20250618","first-page":"10","article-title":"Novel routes of opioid administration in the management of cancer pain","volume":"1","year":"1987","journal-title":"Oncology (Huntingt)"},{"issue":"5","key":"bib26-20250618","first-page":"13","article-title":"Sublingual Roxanol efficacy challenged","volume":"14","year":"1987","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"bib27-20250618","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0304-3959(90)90051-E","article-title":"Steady-state infusions of opioids in human. II. Concentration-effect relationships and therapeutic margins","volume":"43","year":"1990","journal-title":"Pain"},{"issue":"1","key":"bib28-20250618","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-4347(00)86012-0","article-title":"Determination of morphine in cerebrospinal fluid and plasma by high-performance liquid chromatography with electrochemical detection","volume":"232","year":"1982","journal-title":"J Chromatogr"},{"issue":"1","key":"bib29-20250618","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/0742-969X.1990.11882662","article-title":"Cancer pain intensity measurement: concurrent validity of three tools\u2014finger dynamometer, pain intensity number scale, visual analogue scale","volume":"6","year":"1990","journal-title":"Hosp J"},{"issue":"4","key":"bib30-20250618","first-page":"67","article-title":"Pain descriptors used by patients with cancer","volume":"14","year":"1987","journal-title":"Oncol Nurs Forum"},{"issue":"6","key":"bib31-20250618","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/ard.38.6.560","article-title":"Vertical or horizontal visual analogue scales","volume":"38","year":"1979","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"bib34-20250618","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/1097-0142(19870901)60:5<1151::AID-CNCR2820600538>3.0.CO;2-G","article-title":"The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain","volume":"60","year":"1987","journal-title":"Cancer"},{"key":"bib35-20250618","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/nur.4770130405","article-title":"A critical review of visual analogue scales in the measurement of clinical phenomena","volume":"13","year":"1990","journal-title":"Res Nurs Health"},{"issue":"1","key":"bib36-20250618","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/0742-969X.1993.11882756","article-title":"Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer","volume":"9","year":"1993","journal-title":"Hosp J"},{"issue":"4","key":"bib37-20250618","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2125.1985.tb02675.x","article-title":"Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation","volume":"19","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"bib39-20250618","first-page":"Cd003868","article-title":"Oral morphine for cancer pain","volume":"4","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"bib40-20250618","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02220608","article-title":"Evidence for analgesia mediated by peripheral opioid receptors in inflamed synovial tissue","volume":"43","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"bib41-20250618","first-page":"184","article-title":"Sublingual morphine: efficacy reviewed","volume":"16","year":"1998","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"bib42-20250618","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cncr.10636","article-title":"Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion","volume":"95","year":"2002","journal-title":"Cancer"},{"issue":"3","key":"bib43-20250618","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/ijdr.IJDR_379_16","article-title":"Oral changes in patients undergoing chemotherapy for breast cancer","volume":"28","year":"2017","journal-title":"Indian J Dent Res"},{"issue":"3","key":"bib44-20250618","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0304-3959(94)00204-R","article-title":"Chronopharmacokinetic variability in plasma morphine concentrations following oral doses of morphine solution","volume":"61","year":"1995","journal-title":"Pain"},{"issue":"RR-1","key":"bib46-20250618","first-page":"1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States","volume":"65","year":"2016","journal-title":"MMWR Recomm Rep"}],"container-title":["Cancer Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/NCC.0000000000000784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T20:01:25Z","timestamp":1750276885000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/NCC.0000000000000784"}},"subtitle":["A Comparison"],"short-title":[],"issued":{"date-parts":[[2019,12,30]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ncc.0000000000000784","relation":{},"ISSN":["1538-9804","0162-220X"],"issn-type":[{"value":"1538-9804","type":"electronic"},{"value":"0162-220X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,30]]}}}